Literature DB >> 33825717

High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance.

Alena Skalova1, Ilmo Leivo2,3, Henrik Hellquist4, Abbas Agaimy5, Roderick H W Simpson6, Göran Stenman7, Vincent Vander Poorten8,9, Justin A Bishop10, Alessandro Franchi11, Juan C Hernandez-Prera12, David Slouka13, Stefan M Willems14, Kerry D Olsen15, Alfio Ferlito16.   

Abstract

High-grade transformation (HGT) or dedifferentiation has been described in a variety of salivary gland carcinomas, including acinic cell carcinoma, secretory carcinoma, adenoid cystic carcinoma, epithelial-myoepithelial carcinoma, polymorphous adenocarcinoma, low-grade mucoepidermoid carcinoma, and hyalinizing clear cell carcinoma. High-grade (HG) transformed tumors are composed of a conventional low-grade component characterized by specific microscopic and immunohistochemical features for the given entity, intermingled with or juxtaposed to areas of HG morphology. This is usually either poorly differentiated adenocarcinoma, carcinoma not otherwise specified, or undifferentiated carcinoma, in which the original line of differentiation is lost. The HG component is composed of solid nests of anaplastic cells with large vesicular pleomorphic nuclei, prominent nucleoli, and abundant cytoplasm. Frequent mitoses and extensive necrosis may be present. The Ki-67 labeling index is consistently higher in the HG component. The molecular genetic mechanisms responsible for HGT of salivary gland carcinomas are largely unknown, though p53 inactivation and human epidermal growth factor receptor 2 overexpression and/or gene amplification have been demonstrated in the HG component in a few examples, the frequency varies for each histologic type. Salivary gland carcinomas with HGT are more aggressive than conventional carcinomas, with a higher local recurrence rate and a poorer prognosis. They have a high propensity for cervical lymph node metastasis suggesting a need for a wider resection and neck dissection. HGT of salivary gland carcinoma can occur either at initial presentation or less commonly at the time of recurrence, sometimes following postoperative radiotherapy. The potential for HGT in almost any type of salivary gland carcinoma warrants a thorough sampling of all salivary gland malignancies to prevent oversight of a HG component.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33825717     DOI: 10.1097/PAP.0000000000000298

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  5 in total

Review 1.  Development of head and neck pathology in Europe.

Authors:  Henrik Hellquist; Abbas Agaimy; Göran Stenman; Alessandro Franchi; Alfons Nadal; Alena Skalova; Ilmo Leivo; Nina Zidar; Roderick H W Simpson; Pieter J Slootweg; Juan C Hernandez-Prera; Alfio Ferlito
Journal:  Virchows Arch       Date:  2022-01-14       Impact factor: 4.064

2.  Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.

Authors:  Bin Xu; Kartik Viswanathan; Kavita Umrau; Thair A D Al-Ameri; Snjezana Dogan; Kelly Magliocca; Ronald A Ghossein; Nicole A Cipriani; Nora Katabi
Journal:  Histopathology       Date:  2022-09-05       Impact factor: 7.778

3.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.

Authors:  Alena Skálová; Martin D Hyrcza; Ilmo Leivo
Journal:  Head Neck Pathol       Date:  2022-03-21

4.  Expanding the clinicopathological spectrum of TGFBR3-PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high-grade transformation.

Authors:  Niels J Rupp; Sylvia Höller; Muriel Brada; Domenic Vital; Grégoire B Morand; Martina A Broglie; Martin W Huellner; Sandra N Freiberger
Journal:  Genes Chromosomes Cancer       Date:  2021-11-17       Impact factor: 4.263

5.  Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands.

Authors:  Ruben Bill; Daniel G Deschler; Mikael J Pittet; Sara I Pai; Peter M Sadow; Jong Chul Park
Journal:  Cancer Rep (Hoboken)       Date:  2021-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.